Waters Corporation

NYSE:WAT

Medical - Diagnostics & Research

Healthcare
$466.10 -0.16%

-$0.57 today

Market cap
$45.81B
Beta
1.20
P/E (TTM)
65.2
EPS (TTM)
$5.47
52W Low $275.05High $414.15

Volume 0.73M

Average 1.03M

WAT Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Waters CorporationNYSE: WAT

Financing Cash Flow · Q2 FY2026 · quarter ended Jul 2026

Financing cash flow growth accelerates

Q2 FY2026 financing cash flow of $124M (cash outflow) rose 11962.3% year over year, ahead of the -26.6% change in trailing-twelve-month financing cash flow. Sequentially, it fell 41.8% from the prior quarter. Over 3 fiscal years it compounded at -22.5% a year.

Context

  • Financing cash flow amounted to 7.5% of revenue in FY2025, down 16.1 pp from a year earlier.
  • Financing cash flow increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +11962.3% holds above the trailing-twelve-month pace of -26.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
-$124M-41.8% QoQ
Last fiscal yearDec 2025
-$237.21M-66.0% YoY
LTMJul 2026
-$399.93M-26.6% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+11962.3%——
1 year-66.0%——
3-year CAGR-22.5%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
(237.21M) USD
Year-over-year change
+66.0%

Financing Cash Flow vs competitors

How WAT compares with its peers on the latest reported figures

  • WAT's LTM Jul 2026 financing cash flow of $399.93M is the 5th largest of the 7 companies compared; the peer median is $29.95M.
  • Its year-over-year change of -26.6% is the 5th highest of 7, against a peer median of +59.4%.
  • Financing cash flow amounts to 8.6% of revenue for WAT, versus a peer median of 9.7%.
WAT Competitors Peer median
Financing Cash Flow for WAT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DHRDanaher CorporationLTM Sep 2026$8.32B +240.6%+4.8%32.5%
TMOThermo Fisher Scientific Inc.LTM Sep 2026$985M +118.3%—2.1%
MTDMettler-Toledo International Inc.LTM Jun 2026$817.11M +0.5%+1.8%19.8%
RVTYRevvity, Inc.LTM Jul 2026$503.44M -67.2%+8.9%17.3%
WATWaters CorporationLTM Jul 2026$399.93M -26.6%-22.5%8.6%
AAgilent Technologies, Inc.LTM Jul 2026$95M -80.6%-19.5%1.3%
BRKRBruker CorporationLTM Jun 2026$35.1M +205.1%—1.0%
Peer median (excluding WAT) $29.95M+59.4%+3.3%9.7%

Competitors are the stored peer set for WAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income692.84M707.76M642.23M637.83M642.63M
Depreciation & Amortization131.68M130.42M165.91M191.83M206.24M
Deferred Income Tax16.63M(31.99M)(1.2M)(877K)(14.66M)
Stock-Based Compensation29.92M42.56M36.87M44.71M54.13M
Change in Working Capital(107.17M)(269.08M)(240.26M)(111.37M)(233.38M)
Accounts Receivables(62.45M)(137.87M)49.18M(66.24M)(55.5M)
Inventory(67.25M)(101.9M)(45.44M)20.94M(65.93M)
Accounts Payables46.11M60.98M(79.52M)61.59M(89.01M)
Other Working Capital(23.58M)(90.29M)(164.47M)(127.66M)(22.94M)
Other Non-Cash Items(16.63M)31.99M(742K)0(2.4M)
Operating Cash Flow747.27M611.66M602.81M762.12M652.56M
Capital Expenditures(168.27M)(183.46M)(160.63M)(142.48M)(112.75M)
Acquisitions (Net)7M(1.37M)(1.28B)(1.49M)(35.05M)
Purchases of Investments(63.36M)(11.41M)(1.79M)(3.73M)(7.3M)
Sales of Investments218.08M86.9M2.51M3.68M0
Other Investing Activities(225.08M)1.37M002.84M
Investing Cash Flow(231.63M)(107.97M)(1.44B)(144.02M)(152.25M)
Debt Repayment160M60M780M(730M)(243.32M)
Common Stock Issued000020.79M
Common Stock Repurchased(648.93M)(626.06M)(70.28M)(13.54M)(14.67M)
Dividends Paid00000
Other Financing Activities50.66M56.43M45.23M46.87M(7K)
Financing Cash Flow(438.28M)(509.63M)754.95M(696.68M)(237.21M)
Effect of Forex Changes(12.83M)(14.77M)(948K)7.92M(621K)
Net Change in Cash64.54M(20.71M)(85.45M)(70.66M)262.48M
Free Cash Flow579.01M428.21M442.18M619.64M539.81M

Waters Corporation

NYSE:WAT

Intrinsic Alpha fair value

Locked

Current Price

$466.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.